These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 29434372)

  • 1. A stage-dependent link between metabolic syndrome components and incident prostate cancer.
    Hammarsten J; Damber JE; Haghsheno MA; Mellström D; Peeker R
    Nat Rev Urol; 2018 May; 15(5):321-333. PubMed ID: 29434372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Components of the metabolic syndrome and risk of prostate cancer: the HUNT 2 cohort, Norway.
    Martin RM; Vatten L; Gunnell D; Romundstad P; Nilsen TI
    Cancer Causes Control; 2009 Sep; 20(7):1181-92. PubMed ID: 19277881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostate cancer and metabolic syndrome: is there a link?
    McGrowder DA; Jackson LA; Crawford TV
    Asian Pac J Cancer Prev; 2012; 13(1):1-13. PubMed ID: 22502649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic syndrome and prostate cancer risk in a population-based case-control study in Montreal, Canada.
    Blanc-Lapierre A; Spence A; Karakiewicz PI; Aprikian A; Saad F; Parent MÉ
    BMC Public Health; 2015 Sep; 15():913. PubMed ID: 26385727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meta-analysis of metabolic syndrome and prostate cancer.
    Gacci M; Russo GI; De Nunzio C; Sebastianelli A; Salvi M; Vignozzi L; Tubaro A; Morgia G; Serni S
    Prostate Cancer Prostatic Dis; 2017 Jun; 20(2):146-155. PubMed ID: 28220805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calculated fast-growing benign prostatic hyperplasia--a risk factor for developing clinical prostate cancer.
    Hammarsten J; Högstedt B
    Scand J Urol Nephrol; 2002; 36(5):330-8. PubMed ID: 12487736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Midlife metabolic factors and prostate cancer risk in later life.
    Dickerman BA; Torfadottir JE; Valdimarsdottir UA; Wilson KM; Steingrimsdottir L; Aspelund T; Batista JL; Fall K; Giovannucci E; Sigurdardottir LG; Tryggvadottir L; Gudnason V; Markt SC; Mucci LA
    Int J Cancer; 2018 Mar; 142(6):1166-1173. PubMed ID: 29114858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic syndrome and the risk of prostate cancer in Finnish men: a population-based study.
    Laukkanen JA; Laaksonen DE; Niskanen L; Pukkala E; Hakkarainen A; Salonen JT
    Cancer Epidemiol Biomarkers Prev; 2004 Oct; 13(10):1646-50. PubMed ID: 15466982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Sex steroids and adipokines in men with prostate cancer and their relationship with obesity and metabolic syndrome].
    Borowski A; Siemińska L
    Wiad Lek; 2020; 73(1):180-187. PubMed ID: 32124831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lifestyles, health habits, and prostate cancer.
    Kawada T
    J Cancer Res Clin Oncol; 2020 Jun; 146(6):1623-1624. PubMed ID: 30790052
    [No Abstract]   [Full Text] [Related]  

  • 11. Hyperinsulinaemia: a prospective risk factor for lethal clinical prostate cancer.
    Hammarsten J; Högstedt B
    Eur J Cancer; 2005 Dec; 41(18):2887-95. PubMed ID: 16243513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic syndrome and low high-density lipoprotein cholesterol are associated with adverse pathological features in patients with prostate cancer treated by radical prostatectomy.
    Lebdai S; Mathieu R; Leger J; Haillot O; Vincendeau S; Rioux-Leclercq N; Fournier G; Perrouin-Verbe MA; Doucet L; Azzouzi AR; Rigaud J; Renaudin K; Charles T; Bruyere F; Fromont G
    Urol Oncol; 2018 Feb; 36(2):80.e17-80.e24. PubMed ID: 29153942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dissecting the association between metabolic syndrome and prostate cancer risk: analysis of a large clinical cohort.
    Bhindi B; Locke J; Alibhai SMH; Kulkarni GS; Margel DS; Hamilton RJ; Finelli A; Trachtenberg J; Zlotta AR; Toi A; Hersey KM; Evans A; van der Kwast TH; Fleshner NE
    Eur Urol; 2015 Jan; 67(1):64-70. PubMed ID: 24568896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of the USPSTF Grade D Recommendation against Screening for Prostate Cancer on Incident Prostate Cancer Diagnoses in the United States.
    Barocas DA; Mallin K; Graves AJ; Penson DF; Palis B; Winchester DP; Chang SS
    J Urol; 2015 Dec; 194(6):1587-93. PubMed ID: 26087383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obesity, metabolic syndrome, and prostate cancer.
    Hsing AW; Sakoda LC; Chua S
    Am J Clin Nutr; 2007 Sep; 86(3):s843-57. PubMed ID: 18265478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postdiagnostic Statin Use and the Risk of Lethal Prostate Cancer in the Health Professionals Follow-up Study.
    Chan JM; Kenfield SA; Paciorek A; Platz EA; Giovannucci EL; Stampfer MJ
    Cancer Epidemiol Biomarkers Prev; 2015 Oct; 24(10):1638-40. PubMed ID: 26189767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The metabolic syndrome is associated with reduced risk of prostate cancer.
    Tande AJ; Platz EA; Folsom AR
    Am J Epidemiol; 2006 Dec; 164(11):1094-102. PubMed ID: 16968859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between Metformin Use and Cancer Stage at Diagnosis among Elderly Medicare Beneficiaries with Preexisting Type 2 Diabetes Mellitus and Incident Prostate Cancer.
    Raval AD; Mattes MD; Madhavan S; Pan X; Wei W; Sambamoorthi U
    J Diabetes Res; 2016; 2016():2656814. PubMed ID: 27547763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population-based prostate-specific antigen testing in the UK leads to a stage migration of prostate cancer.
    Moore AL; Dimitropoulou P; Lane A; Powell PH; Greenberg DC; Brown CH; Donovan JL; Hamdy FC; Martin RM; Neal DE
    BJU Int; 2009 Dec; 104(11):1592-8. PubMed ID: 19549125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.